Black Diamond Therapeutic... (BDTX)
NASDAQ: BDTX
· Real-Time Price · USD
2.76
-0.03 (-1.08%)
At close: Aug 15, 2025, 3:59 PM
2.77
0.36%
After-hours: Aug 15, 2025, 07:30 PM EDT
Black Diamond Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 70M | 70M | n/a | 4.89M | 4.89M | 4.89M | 4.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 86K | 172K | 258K | 1.08M | 1.81M | 2.53M | 3.25M | 3.24M | 3.24M | 3.24M | 3.23M | 3.05M | 2.69M | 2.22M | 1.41M | 787K | 340K |
Gross Profit | 69.91M | 69.83M | -258K | 4.55M | 3.81M | 3.09M | 2.36M | -3.25M | -3.24M | -3.24M | -3.24M | -3.23M | -3.05M | -2.69M | -2.22M | -1.41M | -787K | -340K |
Operating Income | 4.71M | -4M | -78.78M | -81.36M | -87.24M | -85.14M | -86.46M | -87.46M | -85.57M | -88.71M | -92.83M | -97.06M | -110.3M | -121.84M | -126.87M | -123.97M | -107.09M | -87.4M |
Interest Income | 2.79M | 2.14M | 2.18M | 1.94M | 1.86M | 1.94M | 1.92M | 2.28M | 2.4M | 2.25M | 2.03M | 1.94M | 2.16M | 2.72M | 3.46M | 4.13M | 4.52M | 4.45M |
Pretax Income | 14.44M | 5.09M | -69.68M | -73.1M | -80.55M | -79.79M | -82.44M | -81.86M | -80.51M | -84.29M | -88.92M | -95.96M | -109.38M | -120.8M | -125.6M | -122.36M | -105.19M | -85.41M |
Net Income | 14.44M | 5.09M | -69.68M | -73.1M | -80.55M | -79.79M | -81.76M | -79.4M | -77.01M | -80.16M | -84.9M | -93.72M | -108.17M | -120.22M | -125.6M | -122.36M | -105.19M | -85.41M |
Selling & General & Admin | 20.26M | 25.73M | 27.47M | 27.06M | 29.7M | 27M | 27.11M | 28.79M | 27.21M | 27.31M | 28.39M | 27.56M | 29.02M | 30.04M | 30.04M | 29.05M | 26.87M | 23.73M |
Research & Development | 45.04M | 48.19M | 51.14M | 54.05M | 57.29M | 57.97M | 59.26M | 58.67M | 58.36M | 61.4M | 64.44M | 69.49M | 81.27M | 91.8M | 96.83M | 94.92M | 80.22M | 63.67M |
Other Expenses | n/a | n/a | n/a | n/a | 566K | 907K | 971K | 1.09M | 428K | -56K | -354K | -844K | -1.24M | -1.68M | -2.19M | -1.81M | -1.32M | -740K |
Operating Expenses | 65.3M | 73.92M | 78.61M | 81.1M | 86.98M | 84.97M | 86.37M | 87.46M | 85.57M | 88.71M | 92.83M | 97.06M | 110.3M | 121.84M | 126.87M | 123.97M | 107.09M | 87.4M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 51.88M | 74M | 78.78M | 81.36M | 87.24M | 85.14M | 86.46M | 87.46M | 85.57M | 88.71M | 92.83M | 97.06M | 110.3M | 121.84M | 126.87M | 123.97M | 107.09M | 87.4M |
Income Tax Expense | n/a | n/a | 42.72K | 42.72K | -72.28K | -72.28K | -801K | -2.58M | -3.5M | -4.13M | -4.02M | -2.24M | -1.21M | -578K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 56.8M | 56.66M | 56.61M | 56.51M | 55.16M | 51.81M | 51.64M | 50.94M | 36.52M | 36.48M | 36.39M | 36.35M | 36.29M | 36.27M | 36.23M | 36.22M | 36.18M | 36.12M |
Shares Outstanding (Diluted) | 56.8M | 57.67M | 56.61M | 56.51M | 55.16M | 51.81M | 51.64M | 50.94M | 36.52M | 36.48M | 36.39M | 36.35M | 36.29M | 36.27M | 36.23M | 36.22M | 36.18M | 36.12M |
EPS (Basic) | 0.25 | 0.08 | -1.27 | -1.37 | -1.54 | -1.7 | -1.9 | -1.99 | -2.11 | -2.2 | -2.34 | -2.58 | -2.98 | -3.32 | -3.47 | -3.39 | -2.92 | -2.38 |
EPS (Diluted) | 0.23 | 0.06 | -1.27 | -1.37 | -1.54 | -1.7 | -1.9 | -1.99 | -2.11 | -2.2 | -2.34 | -2.58 | -2.98 | -3.32 | -3.47 | -3.39 | -2.92 | -2.38 |
EBITDA | 4.96M | -3.66M | -78.44M | -81.02M | -86.98M | -84.86M | -86.14M | -87.09M | -85.08M | -88.2M | -92.32M | -96.34M | -109.66M | -121.33M | -126.47M | -123.08M | -105.46M | -85.31M |
EBIT | 18.13M | -4M | -78.78M | -81.36M | -87.24M | -85.14M | -86.46M | -87.46M | -85.57M | -88.71M | -92.83M | -96.84M | -110.08M | -121.63M | -126.66M | -123.42M | -105.97M | -85.82M |
Depreciation & Amortization | 258K | 344K | 343K | 344K | 1.08M | 1.81M | 2.53M | 3.25M | 3.24M | 3.24M | 3.24M | 3.23M | 3.05M | 2.69M | 2.22M | 1.43M | 816K | 382K |